ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Early Post Renal Transplant aHUS in Patients with Heterozygous CFHR3-CFHR1 Deletion.

    S. Rhazouani, A. Malone, T. Alhamad, T. Maw, D. Brennan, R. Delos Santos.

    Renal Division, Washington University, Saint Louis, MO.

    Background: Atypical hemolytic uremic syndrome (aHUS) is a rare disease with a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Subjects homozygous for…
  • 2016 American Transplant Congress

    Learning Curve of Laparoscopic Donor Nephrectomy for Abdominal Transplant Surgery Fellows.

    O. Serrano,1 A. Bangdiwala,2 D. Vock,3 V. Kirchner,1 T. Dunn,1 E. Finger,1 T. Pruett,1 A. Matas,1 R. Kandaswamy.1

    1Surgery, Univ. of Minnesota, Minneapolis, MN; 2Biostatistics, Masonic Cancer Center, Minneapolis, MN; 3Biostatistics, Univ. of Minnesota, Minneapolis, MN.

    PURPOSE: Laparoscopic donor nephrectomy (LDN) requires a high degree of surgical competence and skill. UNOS recommends that fellowship-trained surgeons participate in 15 LDN to be…
  • 2016 American Transplant Congress

    Phenotype and Outcome of Antibody-Mediated Rejection Due to Pre-Existing and De Novo DSA in Kidney Recipients.

    O. Aubert,1 A. Loupy,1 L. Hidalgo,2 J. Reeve,3 D. Glotz,1 C. Legendre,1 C. Lefaucheur,1 P. Halloran.3

    1Paris Research Center for Organ Transplantation, Paris, France; 2University of Alberta, Edmonton, Canada; 3ATAGC, Edmonton, Canada.

    Antibody-mediated rejection (ABMR) presents with either pre-existing or de novo DSA. The aim of the study was to compare the two ABMR phenotypes and their…
  • 2016 American Transplant Congress

    Lower Rates of Living Donor Kidney Transplantation(LD) Among African Americans: What Prevents Higher Rates of Donation?

    A. Li, N. Foreman, M. Reissmann, C. Zuttermeister, A. Gilbert, M. Grafals, B. Javaid, S. Ghasemian, P. Abrams, M. Cooper, J. Verbesey.

    MedStar Georgetown Transplant Institute, Washington, DC.

    Purpose: African Americans (AA) are less likely to undergo LD kidney transplantation. Reasons may include decreased health literacy, increased obesity, or hypertension. We sought to…
  • 2016 American Transplant Congress

    Implications of Subclinical Borderline Acute Cellular Rejection Detected in Protocol Biopsies on Graft Outcomes.

    Z. Zaky,1 C. Yu,1 N. Elfadawy,2 A. Chiesa-Vottero,1 L. Herlitz,1 S. Flechner,1 E. Poggio.1

    1Glickman Urological and Kidney institute, Cleveland Clinic, Cleveland, OH; 2Internal Medicine, Univ. Hospitals Case Medical Center, Cleveland, OH.

    Background: The effects of subclinical borderline acute cellular rejection (BACR-defined as I1T1 per Banff criteria) detected in protocol biopsies (Bx) on subsequent graft function and…
  • 2016 American Transplant Congress

    Removing Geographic and Financial Barriers for Directed Living Kidney Donations: Lessons from Kidney Paired Donation.

    M. Aeder,1 R. Leishman,2 D. Stewart.2

    1Univ Hosp Case Med Ctr, Cleveland, OH; 2UNOS, Richmond, VA.

    Living donor (LD) kidney (K) transplants (Tx), which peaked at 6647 in 2004 (42.5% of tx), decreased by 2014 to 5538 (32.4% of tx). Although…
  • 2016 American Transplant Congress

    ABO Incompatible Living Related Kidney Transplantation: Results of a Matched-Pair Analysis with ABO Compatible Living Donation.

    T. Vowinkel,1 H. Wolters,2 S. Reuter,3 T. Vogel,1 N. Senninger,1 B. Suwelack.3

    1Department of General and Visceral Surgery, University Hospital Muenster, Muenster, Germany; 2Department of General and Visceral Surgery, St. Josef's Hospital, Dortmund, Germany; 3Department of Internal Medicine D, University Hospital Muenster, Muenster, Germany.

    Background: Organ shortage has led to an increase in living related kidney transplantation of ABO compatible (ABOc) as well as ABO incompatible (ABOi) organs. Here…
  • 2016 American Transplant Congress

    Age and Education Level Are Predictors of Patient Preferences for Educational Formats in ESRD Patients Undergoing Transplant Education.

    K. Leick,1 J. Jones,1 S. Witte,2 L. Hunsicker,3 Z. Stewart.1

    1Dept of Surgery, University of Iowa, Iowa City, IA; 2Dept of Social Services, University of Iowa, Iowa City, IA; 3Dept of Internal Medicine, University of Iowa, Iowa City, IA.

    Background: Health literacy impacts hospitalizations and mortality. ESRD patients have reduced health literacy due to a high proportion of lower educational background and socioeconomic resources.…
  • 2016 American Transplant Congress

    Limited Efficacy of Bortezomib on Desensitization via Rapid Humoral Compensation in a Sensitized Rhesus Model.

    J. Kwun,1 C. Burghuber,1 N. Iwakoshi,2 A. Gibby,2 S. Knechtle.1

    1Surgery, Duke University, Durham; 2Surgery, Emory University, Atlanta.

    Sensitized patients comprise a significant proportion (30%) of candidates on the waiting list for transplantation. With recent evidence that the presence of donor-specific antibodies (DSA)…
  • 2016 American Transplant Congress

    Immunologic Basis for Immunocloaking.

    L. Brasile,1 K. Kizjakina,1 N. Henry,1 B. Stubenitsky.2

    1BREONICS Inc., Watervliet, NY; 2Plastic Surgery, University of Utrecht, Utrecht, Netherlands.

    A novel organ-specific immunomodifying therapy referred to as immunocloaking (IC) provides protection from early allograft rejection without immunosuppressive drugs. The IC binds to the surfaces…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences